Preanalytics in urinalysis

Clinical Biochemistry

Volumn 49, Issue 18, 2016, Pages 1346-1350

  Delanghe, Joris R ^a   Speeckaert, Marijn M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Dilution; Preservatives; Sample preparation; Urinalysis

Indexed keywords

PRESERVATIVE;

ANALYTIC METHOD; ANALYTICAL ERROR; CLINICAL LABORATORY; DILUTION; DIURESIS; HUMAN; METABOLOMICS; PATIENT SAFETY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; STORAGE; TEST STRIP; TOXICOLOGY; URINALYSIS; URINE SAMPLING; PROCEDURES; SPECIMEN HANDLING;

HUMANS; METABOLOMICS; PROTEOMICS; SPECIMEN HANDLING; URINALYSIS;

EID: 84999636145     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.10.016     Document Type: Review

References (63)

1. [1] Coppens, A., Speeckaert, M., Delanghe, J., The pre-analytical challenges of routine urinalysis. Acta Clin. Belg. 65 (2010), 182–189.
2. [2] Delanghe, J., Speeckaert, M., Preanalytical requirements of urinalysis. Biochem. Med. (Zagreb) 24 (2014), 89–104.
3. [3] Guder, W.G., Delanghe, J., 2.7 Spot or Timed Urine – Preanalytical Aspects of Urinalysis. Guder, W.G., (eds.) Pre-Examination Procedures in Laboratory Diagnostics, 2015, de Gruyter, 69–80.
4. [4] Hanneman-Pohl, K., Kampf, S.C., Automation of urine sediment examination: a comparison of the Sysmex UF-100 automated flow cytometer with routine manual diagnosis. Clin. Chem. Lab. Med. 37 (1999), 753–764.
5. [5] Carlson, D.A., Statland, B.E., Automated urinalysis. Clin. Lab. Med. 8 (1988), 449–461.
6. [6] Khejonnit, V., Pratumvinit, B., Reesukumal, K., Meepanya, S., Pattanavin, C., Wongkrajang, P., Optimal criteria for microscopic review of urinalysis following use of automated urine analyzer. Clin. Chim. Acta 439 (2015), 1–4.
7. [7] Lippi, G., Becan-McBride, K., Behulova, D., et al. Preanalytical quality improvement: in quality we trust. Clin. Chem. Lab. Med. 51 (2013), 229–241.
8. [8] Stankovic, A.K., DeLauro, E., Quality improvements in the pre-analytical phase: focus on urine specimen workflow. Clin. Lab. Med. 28 (2008), 339–350.
9. [9] Dikmen, Z.G., Pinar, A., Akbiyik, F., Specimen rejection in laboratory medicine: necessary for patient safety?. Biochem. Med. (Zagreb) 25 (2015), 377–385.
10. [10] Delanghe, J.R., New screening diagnostic techniques in urinalysis. Acta Clin. Belg. 62 (2007), 155–161.
11. [11] European Confederation of Laboratory Medicine, European urinalysis guidelines. Scand. J. Clin. Lab. Invest. Suppl. 231 (2000), 1–86.
12. [12] Clinical and Laboratory Standards Institute (CLSI), Urinalysis and Collection, Transportation and Preservation of Urine Specimens. Approved guideline. CLSI-Document GP16-A3, 3rd ed., 2009 ( http://www.clsi.org/, (accessed 10.07.16).
13. [13] Ekşioğlu, M.K., Madenci, Ö.Ç., Yücel, N., et al. The effectiveness of BD Vacutainer® Plus urinalysis preservative tubes in preservation of urine for chemical strip analysis and particle counting. Biochem. Med. (Zagreb) 26 (2016), 224–232.
14. [14] Clinical and Laboratory Standards Institute, Urinalysis and Collection, Transportation, and Preservation of Urine Specimens; Approved Guideline. NCCLS document GP16-A3, Third edition, 2009 ( http://www.clsi.org/, accessed 10.07.16).
15. [15] Norden, C.W., Kass, E.H., Bacteriuria of pregnancy - a critical appraisal. Annu. Rev. Med. 19 (1968), 431–470.
16. [16] Roberts, A.P., Robinson, I.E., Beard, R.W., Some factors affecting bacterial colony counts in urinary infection. Br. Med. J. 1 (1967), 400–403.
17. [17] Dinda, A.K., Saxena, S., Guleria, S., et al. Diagnosis of glomerular haematuria: role of dysmorphic red cell, G1 cell and bright-field microscopy. Scand. J. Clin. Lab. Invest. 57 (1997), 203–208.
18. [18] Manoni, F., Gessoni, G., Alessio, M.G., et al. Mid-stream vs. first-voided urine collection by using automated analyzers for particle examination in healthy subjects: an Italian multicenter study. Clin. Chem. Lab. Med. 50 (2012), 679–684.
19. [19] Kouri, T.T., Gant, V.A., Fogazzi, G.B., Hofmann, W., Hallander, H.O., Guder, W.G., Towards European urinalysis guidelines. Introduction of a project under European Confederation of Laboratory Medicine. Clin. Chim. Acta 297 (2000), 305–311.
20. [20] Dolscheid-Pommerich, R.C., Klarmann-Schulz, U., Conrad, R., Stoffel-Wagner, B., Zur, B., Evaluation of the appropriate time period between sampling and analyzing for automated urinalysis. Biochem. Med. (Zagreb) 26 (2016), 82–89.
21. [21] https://iqmh.org.
22. [22] Guder, W.G., Fiedler, M., da Fonseca Wollheim, F., et al. The Quality of Diagnostic Samples. fourth ed., 2014, BD Diagnostics, Oxford.
23. [23] Fogazzi, G.B., Ponticelli, C., Ritz, E., The Urinary Sediment. An Integrated View. 1999, Oxford University Press, New York.
24. [24] Eisinger, S.W., Schwartz, M., Dam, L., Riedel, S., Evaluation of the BD Vacutainer Plus Urine C&S preservative tubes compared with nonpreservative urine samples stored at 4 °C and room temperature. Am. J. Clin. Pathol. 140 (2013), 306–313.
25. [25] Gillespie, T., Fewster, J., Masterton, R.G., The effect of specimen processing delay on borate urine preservation. J. Clin. Pathol. 52 (1999), 95–98.
26. [26] Kouri, T., Malminiemi, O., Penders, J., Pelkonen, V., Vuotari, L., Delanghe, J., Limits of preservation of samples for urine strip tests and particle counting. Clin. Chem. Lab. Med. 46 (2008), 703–713.
27. [27] Fabbro, C., Darolles, J., Rault, J.P., Preservation of urine samples for UF 1000i (bioMérieux©) analysis. Ann. Biol. Clin. (Paris) 69 (2011), 588–592.
28. [28] Thongboonkerd, V., Saetun, P., Bacterial overgrowth affects urinary proteome analysis: recommendation for centrifugation, temperature, duration, and the use of preservatives during sample collection. J. Proteome Res. 6 (2007), 4173–4181.
29. [29] Ercan, M., Akbulut, E.D., Abuşoğlu, S., et al. Stability of urine specimens stored with and without preservatives at room temperature and on ice prior to urinalysis. Clin. Biochem. 48 (2015), 919–922.
30. [30] Shirreffs, S.M., Maughan, R.J., Urine osmolality and conductivity as indices of hydration status in athletes in the heat. Med. Sci. Sports Exerc. 30 (1998), 1598–1602.
31. [31] McCrossin, T., Roy, L.P., Comparison of hydrometry, refractometry, osmometry, and Ames N-Multistix SG in estimation of urinary concentration. Aust. Paediatr. J. 21 (1985), 185–188.
32. [32] Brandon, C.A., Urine specific gravity measurement: reagent strip versus refractometer. Clin. Lab. Sci. 7 (1994), 308–310.
33. [33] Dorizzi, R.M., Caputo, M., Measurement of urine relative density using refractometer and reagent strips. Clin. Chem. Lab. Med. 36 (1998), 925–928.
34. [34] Crespi, V., Maio, R.C., Veronesi, G., Gianfagna, F., Taborelli, S., Ferrario, M.M., Workplace drug testing on urine samples: evidence for improving efficacy of a first-level screening programme. Med. Lav. 106 (2015), 374–385.
35. [35] Giasson, J., Chen, Y., A discrepant urine specific gravity. Clin. Chem. 58 (2012), 797–802.
36. [36] Adams, L.J., Evaluation of Ames Multistix-SG for urine specific gravity versus refractometer specific gravity. Am. J. Clin. Pathol. 80 (1983), 871–873.
37. [37] Langlois, M., Delanghe, J.R., Steyaert, R.S., Everaert, K.C., DeBuyzere, M.L., Automated flow cytometry compared with an automated dipstick reader for urinalysis. Clin. Chem. 45 (1999), 118–122.
38. [38] Baxmann, A.C., Ahmed, M.S., Marques, N.C., et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin. J. Am. Soc. Nephrol. 3 (2008), 348–354.
39. [39] Mundt, L., Shanahan, K., Graff's Textbook of Urinalysis and Body Fluids. 2nd ed., 2010, Wolters Kluwer, Philadelphia.
40. [40] Smith, B.C., Peake, M.J., Fraser, C.G., Urinalysis by use of multi-test reagent strips: two dipsticks compared. Clin. Chem. 23 (1977), 2337–2340.
41. [41] Brandt, R., Guyer, K.E., Jr, W.L., Banks, urinary glucose and vitamin C. Am. J. Clin. Pathol. 68 (1977), 592–594.
42. [42] Court, J.M., Davies, H.E., Ferguson, R., Diastix and ketodiastix: a new semiquantitative test for glucose in urine. Med. J. Aust. 1 (1972), 525–528.
43. [43] Wilson, D.M., Urinalysis and other tests of renal function. Minn. Med. 58 (1975), 9–17.
44. [44] Rasoulpour, M., McLean, R.H., Raye, J., Shah, B.L., Pseudohematuria in neonates. J. Pediatr. 92 (1978), 852–853.
45. [45] Patel, H.P., The abnormal urinalysis. Pediatr. Clin. North Am. 53 (2006), 325–337.
46. [46] Chanoine, J.P., Bourdoux, P., Vo Thi, N.B., Ermans, A.M., Iodine contamination of urine samples by test strips. Clin. Chem., 33, 1987, 1935.
47. [47] Van Acker, J.T., Verstraete, A.G., Van Hamme, M.A., Delanghe, J., Falsely increased urinary caffeine attributable to contamination by urine test strips. Clin. Chem. 45 (1999), 1315–1317.
48. [48] Budde, K., Gök, Ö.N., Pietzner, M., et al. Quality assurance in the pre-analytical phase of human urine samples by (1)H NMR spectroscopy. Arch. Biochem. Biophys. 589 (2016), 10–17.
49. [49] Bernini, P., Bertini, I., Luchinat, C., Nincheri, P., Staderini, S., Turano, P., Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J. Biomol. NMR 49 (2011), 231–243.
50. [50] Yuille, M., Illig, T., Hveem, K., et al. Laboratory management of samples in biobanks: European consensus expert group report. Biopreserv. Biobank. 8 (2010), 65–69.
51. [51] Beckonert, O., Keun, H.C., Ebbels, T.M., et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2 (2007), 2692–2703.
52. [52] Emwas, A.-H., Luchinat, C., Turano, P., et al. Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review. Metabolomics 11 (2015), 872–894.
53. [53] Hepburn, S., Cairns, D.A., Jackson, D., et al. An analysis of the impact of pre-analytical factors on the urine proteome: sample processing time, temperature, and proteolysis. Proteomics Clin. Appl. 9 (2015), 507–521.
54. [54] Ellervik, C., Vaught, J., Preanalytical variables affecting the integrity of human biospecimens in biobanking. Clin. Chem. 61 (2015), 914–934.
55. [55] Kandall, S.R., Improving treatment for drug-exposed infants treatment improvement protocol (TIP) Series 5. http://www.ncbi.nlm.nih.gov/books/NBK64750/, 1993 (accessed 10.07.16).
56. [56] European Workplace Drug Testing Society (EWDTS), European Laboratory Guidelines for Legally Defensible Workplace Drug Testing. http://www.ewdts.org/, 2002 (accessed 04.07.16).
57. [57] Department of Health and Human Services - Substance Abuse and Mental Health Services Administration, Mandatory guidelines for federal workplace drug testing programs. https://www.federalregister.gov/articles/2015/05/15/2015-11523/mandatory-guidelines-for-federal-workplace-drug-testing-programs/, 2015 (accessed 07.07.16).
58. [58] Swiss Working Group for Drugs of Abuse Testing Guidelines (AGSA), Drugs of abuse testing guidelines. http://faculty.ksu.edu.sa/18856/454/AGSA%20%20Drugs%20of%20Abuse%20Testing%20Guidelines.pdf/, 2012 (accessed 03.07.16).
59. [59] Joint Technical Committee CH-036 Analysis of Body Fluids and Wastes, Australian/New Zealand Standard TM: Procedures for the collection, detection and quantitation of drugs of abuse in urine. http://www.sai-global.com/pdftemp/previews/osh/as/as4000/4300/4308.pdf/, 2001 (accessed 01.06.16).
60. [60] Penders, J., Verstraete, A., Laboratory guidelines and standards in clinical and forensic toxicology. Accred. Qual. Assur. 11 (2006), 284–290.
61. [61] Clinical and Laboratory Standards Institute, Urine drug testing in the clinical laboratory; approved guideline. NCCLS/CLSI T/DM8-A, 1999 ( http://www.clsi.org/, accessed 05.07.16).
62. [62] Stout, P.R., Klette, K.L., Horn, C.K., Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays. J. Forensic Sci. 49 (2004), 160–164.
63. [63] Lachenmeier, D.W., Sproll, C., Musshoff, F., Poppy seed foods and opiate drug testing–where are we today?. Ther. Drug Monit. 32 (2010), 11–18.